NATR
Nature's Sunshine Products, Inc.22.38
-0.85-3.66%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Key Stats
Market Cap
394.68MP/E (TTM)
27.63Basic EPS (TTM)
0.81Dividend Yield
0%Recent Filings
10-K
FY2025 results
Nature's Sunshine delivered FY2025 net sales of $480.1M, up 5.7% y/y, with Asia (+6.7%), Europe (+9.8%), and North America (+3.4%) driving gains while Latin America dipped 5.5%; gross margins expanded to 72.4% from cost savings, yet SG&A rose to 37.2% on marketing and China service fees, yielding operating income of $24.7M. Q4 saw aggressive share repurchases of 131K shares, part of $16.3M annual buybacks leaving $17.4M authorized. Cash swelled to $93.9M with $35.3M operating inflow. China JV fully acquired December 17. Ongoing Ukraine conflict curbs Eastern Europe momentum.
8-K
Strong Q4, FY sales growth
Nature's Sunshine reported Q4 net sales up 4.7% to $123.8M and full-year up 5.7% to $480.1M, with GAAP net income swinging to $19.5M from $7.7M. Digital channels exploded 47%, new customers up 98%; Europe surged 18%. Adjusted EBITDA hit $49.4M, up 21.7%. Guides 2026 sales $500-515M. Cash swelled to $93.9M debt-free; repurchased $16.3M stock.
10-Q
Q3 FY2025 results
Nature's Sunshine posted solid Q3 momentum with net sales up 12.0% y/y to $128.3M, driven by 17.1% Asia growth while Latin America dipped 13.1%; gross margin expanded to 73.3% from 71.3% on cost savings and mix. Operating income rose 69.9% y/y to $9.0M, diluted EPS held steady at $0.30 amid share repurchases (anti-dilution flagged), reconciling to 18,034 diluted shares. Cash swelled to $95.6M with $25.4M YTD operating cash flow; $25M revolver undrawn, covenants met. China JV buyouts pending for $7.0M cash. Trade control self-disclosures loom as a wildcard.
8-K
Q3 sales up 12%, outlook raised
Nature's Sunshine crushed Q3 with net sales up 12% to $128.3 million and adjusted EBITDA soaring 42% to $15.2 million, fueled by Asia's 17% surge and North America Digital's 52% leap. Gross margins hit 73.3%, the highest in 15 quarters, thanks to cost savings. Raised full-year outlook to $476-480M sales, $47-49M EBITDA. New CEO joins mid-momentum.
8-K
Romanyi named NATR CEO
Nature's Sunshine appointed Kenneth Romanzi as CEO and board member effective October 29, 2025, succeeding Terrence O. Moorehead who resigns that day after announcing his departure in May. Romanzi, 65, brings 40+ years in CPG leadership, including CEO of B&G Foods. New deal offers $850,000 base, $3M RSUs/PSUs. Smooth transition, yet leadership shift tests execution.
IPO
Employees
Sector
Industry
BFNH
BioForce Nanosciences Holdings,
0.60+0.07
HAIN
The Hain Celestial Group, Inc.
1.11-0.06
HCWC
Healthy Choice Wellness Corp.
0.27-0.00
HLF
Herbalife Ltd.
14.45-0.45
LFVN
Lifevantage Corporation
6.33-0.12
LIMX
Limitless X Holdings Inc.
1.40+0.00
NAII
Natural Alternatives Internatio
3.19-0.01
NPRFF
NEPRA FOODS INC.
0.10+0.00
NUS
Nu Skin Enterprises, Inc.
10.51+0.01
USNA
USANA Health Sciences, Inc.
20.33+0.01